TroFuse-020/GOG-3101/ENGOT-Cx20: A Phase 3, Randomised, Active-Controlled, Open-Label, Multicentre Study Comparing Sacituzumab Tirumotecan Monotherapy Vs Treatment Of Physician’s Choice As Second-Line Treatment For Recurrent Or Metastatic Cervical Cancer
医学
打开标签
二线治疗
外科
随机对照试验
总体生存率
作者
Ritu Salani,Kristina Yvonne Lindemann,Zhongqiu Lin,Shin Nishio,Ana Oaknin,Jean‐Emmanuel Kurtz,Giorgio Valabrega,M. Valeria Cáceres,Philipp Harter,Lucy Gilbert,Azmat Sadozye,Lilian Arruda Do Rêgo Barros,Toon Van Gorp,Ingrid A Boere,Christian Marth,Linda Duska,Bradley J. Monk,Xin Tong Li,Cumhur Tekin,Mansoor Raza Mirza
PDF的下载单位、IP信息已删除
(2025-6-4)
null
C.Cat
学霸业
GingerF
学术雷锋
清风徐来
Mic
吃葡萄不吐葡萄皮
Criminology34
June
无极微光
auqkhter
秋风
sanvva
may
v0id
俊逸的映易
以七
初景
散逸层梦游
皖公网安备34019202002308
